Instruction for use: SalozinalI want this, give me price
Active substance Mesalazine
ATX Code A07EC02 Mesalazine
NSAIDs - Salicylic acid derivatives
Nosological classification (ICD-10)
K50 Crohn's disease [regional enteritis]
Crohn's disease, Crohn's disease with fistula, Granuloma of the intestine, Granulomatous enteritis, Crohn's disease, Regional ileitis, Terminal Ileitis, Enteritis regional
K51 Ulcerative colitis
Colitis acute ulcerative, Colitis ulcerative, Ulcerative-necrotic colitis, Colitis ulcerative-hemorrhagic nonspecific, Colitis ulcerative and trophic, Colitis ulcerative idiopathic, Colitis ulcerative nonspecific, Nonspecific ulcerative colitis, Proctocolitis ulcers, Hemorrhagic purulent rectoxitis, Rectoccolitis ulcerative-hemorrhagic
Composition and form of release
1 tablet contains mesalazine 250 mg, in a package of 50 pcs.
Pharmacological action - anti-inflammatory, antibacterial.
Salosinal, thanks to a special tablet coating, releases mesalazine, the active metabolite of sulfasalazine, mainly in the large intestine (60-79%). In the jejunum, 15-30% of the active substance is released, with only about 10% entering the systemic circulation.
Nonspecific ulcerative colitis; Crohn's disease (prevention and treatment of exacerbations).
Hypersensitivity, severe hepatic-renal failure, gastric and duodenal ulcer, hemorrhagic diathesis.
pregnancy and lactation
It is not recommended to use the drug during pregnancy and during lactation.
Weakness, headache, bronchospasm, pseudo erythritis, methemoglobinemia, allergic reactions.
Increases the toxicity of methotrexate, sulfonamides, furosemide and rifampicin. It increases the hypoglycemic effect of sulfonylurea derivatives and the ulcerogenic effect of glucocorticosteroids.
Dosing and Administration
Inside, after eating, with plenty of water; with exacerbation of colitis - 2-3 tablets 3 times a day. For the prevention of relapse - 1-2 tablets 3 times a day.
Symptoms: nausea, vomiting, epigastric pain, weakness, drowsiness. Treatment: gastric lavage, laxative, symptomatic therapy.
It is recommended to conduct a regular blood and urine test with prolonged therapy.
In a dry place, at room temperature.
Keep out of the reach of children.
Do not use after the expiry date printed on the package.